Levofloxacin Plus Metronidazole Suppositories
PreclinicalSmall molecule
Levofloxacin Plus Metronidazole Suppositories is one of 11 small molecule programs targeting Endometritis. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
10
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
16 competitors in Endometritis
#DrugCompanyPhaseTrials
1Acanya
PfizerApproved
Ancef
BBaxter Healthcare Corporation
Approved
Rocephin
CConrado Roberto Hoffmann Filho
Approved
Invanz
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Approved
Betadine
BBecton, Dickinson and Company
Preclinical
Oral Administration
BBiomind Labs Inc.
Phase 2
Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Peridex
MMedline Industries
Preclinical
Antibiotic Administration
UUniversity of California, San Diego
Phase 2
Antibiotics
MMelinta Therapeutics, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- PPeking University Third Hospital